TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-1 expression in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression

Jonathan M. Weiss, Carolyn A. Cuff, Joan W. Berman

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The expression of chemokines, including monocyte chemoattractant protein (MCP)-1, by many cell types contributes to the pathogenesis of inflammatory diseases. We examined MCP-1 expression in human umbilical vein endothelial cells (EC) following cytokine treatment. We specifically compared the effect of TGF-β1 on this cytokine-induced expression, as TGF-β has been shown to have immunosuppressive effects on EC. EC expressed MCP-1 mRNA and protein in response to TNFα, IFNγ or IL-1β, but not TGF-β1. TGF-β1 in cotreatment with either TNFα or IL-1β, but not IFNγ, significantly decreased MCP-1 mRNA and protein expression, as compared to TNFα or IL-1β treatment alone. Pretreatment with TGF-β had no effect on any cytokine-induced MCP-1 expression. TGF-β had no effect on MCP-1 mRNA stability. Examination of TNF receptor expression by flow cytometry revealed that TNFα treatment caused a decrease of p75 expression on the cell surface. The p55 receptor was not detected at the cell surface, but was localized intracellularly by confocal microscopy. Treatment of EC with TGF-β alone decreased p75 surface expression and in cotreatment with TNFα, caused an additive decrease in p75 surface expression, as compared to TNFα treatment alone. Whereas mRNA expression for both receptors was increased with TNFα treatment, this was decreased with TGF-β/TNFα cotreatment, as compared to TNFα treatment alone. Thus, the expression of TNF receptors was also down-modulated by TGF-β. These findings indicate additional mechanisms by which TGF-β exerts immunosuppressive properties on EC.

Original languageEnglish (US)
Pages (from-to)291-302
Number of pages12
JournalEndothelium: Journal of Endothelial Cell Research
Volume6
Issue number4
StatePublished - 1999

Fingerprint

Chemokine CCL2
Tumor Necrosis Factor Receptors
Transforming Growth Factor beta
Endothelial Cells
Cytokines
Interleukin-1
Immunosuppressive Agents
Messenger RNA
Human Umbilical Vein Endothelial Cells
RNA Stability
Chemokines
Confocal Microscopy
Flow Cytometry
Proteins

Keywords

  • Endothelial cells
  • Monocyte chemoattractant protein-1
  • TNF receptors
  • Transforming growth factor-beta

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

@article{e9dca68ea2934b6d9c91d792425c4304,
title = "TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-1 expression in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression",
abstract = "The expression of chemokines, including monocyte chemoattractant protein (MCP)-1, by many cell types contributes to the pathogenesis of inflammatory diseases. We examined MCP-1 expression in human umbilical vein endothelial cells (EC) following cytokine treatment. We specifically compared the effect of TGF-β1 on this cytokine-induced expression, as TGF-β has been shown to have immunosuppressive effects on EC. EC expressed MCP-1 mRNA and protein in response to TNFα, IFNγ or IL-1β, but not TGF-β1. TGF-β1 in cotreatment with either TNFα or IL-1β, but not IFNγ, significantly decreased MCP-1 mRNA and protein expression, as compared to TNFα or IL-1β treatment alone. Pretreatment with TGF-β had no effect on any cytokine-induced MCP-1 expression. TGF-β had no effect on MCP-1 mRNA stability. Examination of TNF receptor expression by flow cytometry revealed that TNFα treatment caused a decrease of p75 expression on the cell surface. The p55 receptor was not detected at the cell surface, but was localized intracellularly by confocal microscopy. Treatment of EC with TGF-β alone decreased p75 surface expression and in cotreatment with TNFα, caused an additive decrease in p75 surface expression, as compared to TNFα treatment alone. Whereas mRNA expression for both receptors was increased with TNFα treatment, this was decreased with TGF-β/TNFα cotreatment, as compared to TNFα treatment alone. Thus, the expression of TNF receptors was also down-modulated by TGF-β. These findings indicate additional mechanisms by which TGF-β exerts immunosuppressive properties on EC.",
keywords = "Endothelial cells, Monocyte chemoattractant protein-1, TNF receptors, Transforming growth factor-beta",
author = "Weiss, {Jonathan M.} and Cuff, {Carolyn A.} and Berman, {Joan W.}",
year = "1999",
language = "English (US)",
volume = "6",
pages = "291--302",
journal = "Endothelium: Journal of Endothelial Cell Research",
issn = "1062-3329",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-1 expression in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression

AU - Weiss, Jonathan M.

AU - Cuff, Carolyn A.

AU - Berman, Joan W.

PY - 1999

Y1 - 1999

N2 - The expression of chemokines, including monocyte chemoattractant protein (MCP)-1, by many cell types contributes to the pathogenesis of inflammatory diseases. We examined MCP-1 expression in human umbilical vein endothelial cells (EC) following cytokine treatment. We specifically compared the effect of TGF-β1 on this cytokine-induced expression, as TGF-β has been shown to have immunosuppressive effects on EC. EC expressed MCP-1 mRNA and protein in response to TNFα, IFNγ or IL-1β, but not TGF-β1. TGF-β1 in cotreatment with either TNFα or IL-1β, but not IFNγ, significantly decreased MCP-1 mRNA and protein expression, as compared to TNFα or IL-1β treatment alone. Pretreatment with TGF-β had no effect on any cytokine-induced MCP-1 expression. TGF-β had no effect on MCP-1 mRNA stability. Examination of TNF receptor expression by flow cytometry revealed that TNFα treatment caused a decrease of p75 expression on the cell surface. The p55 receptor was not detected at the cell surface, but was localized intracellularly by confocal microscopy. Treatment of EC with TGF-β alone decreased p75 surface expression and in cotreatment with TNFα, caused an additive decrease in p75 surface expression, as compared to TNFα treatment alone. Whereas mRNA expression for both receptors was increased with TNFα treatment, this was decreased with TGF-β/TNFα cotreatment, as compared to TNFα treatment alone. Thus, the expression of TNF receptors was also down-modulated by TGF-β. These findings indicate additional mechanisms by which TGF-β exerts immunosuppressive properties on EC.

AB - The expression of chemokines, including monocyte chemoattractant protein (MCP)-1, by many cell types contributes to the pathogenesis of inflammatory diseases. We examined MCP-1 expression in human umbilical vein endothelial cells (EC) following cytokine treatment. We specifically compared the effect of TGF-β1 on this cytokine-induced expression, as TGF-β has been shown to have immunosuppressive effects on EC. EC expressed MCP-1 mRNA and protein in response to TNFα, IFNγ or IL-1β, but not TGF-β1. TGF-β1 in cotreatment with either TNFα or IL-1β, but not IFNγ, significantly decreased MCP-1 mRNA and protein expression, as compared to TNFα or IL-1β treatment alone. Pretreatment with TGF-β had no effect on any cytokine-induced MCP-1 expression. TGF-β had no effect on MCP-1 mRNA stability. Examination of TNF receptor expression by flow cytometry revealed that TNFα treatment caused a decrease of p75 expression on the cell surface. The p55 receptor was not detected at the cell surface, but was localized intracellularly by confocal microscopy. Treatment of EC with TGF-β alone decreased p75 surface expression and in cotreatment with TNFα, caused an additive decrease in p75 surface expression, as compared to TNFα treatment alone. Whereas mRNA expression for both receptors was increased with TNFα treatment, this was decreased with TGF-β/TNFα cotreatment, as compared to TNFα treatment alone. Thus, the expression of TNF receptors was also down-modulated by TGF-β. These findings indicate additional mechanisms by which TGF-β exerts immunosuppressive properties on EC.

KW - Endothelial cells

KW - Monocyte chemoattractant protein-1

KW - TNF receptors

KW - Transforming growth factor-beta

UR - http://www.scopus.com/inward/record.url?scp=0032838418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032838418&partnerID=8YFLogxK

M3 - Article

C2 - 10475092

AN - SCOPUS:0032838418

VL - 6

SP - 291

EP - 302

JO - Endothelium: Journal of Endothelial Cell Research

JF - Endothelium: Journal of Endothelial Cell Research

SN - 1062-3329

IS - 4

ER -